STOCK TITAN

Rxsight, Inc. SEC Filings

RXST NASDAQ

Welcome to our dedicated page for Rxsight SEC filings (Ticker: RXST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The RxSight, Inc. (RXST) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. RxSight is an ophthalmic medical device company focused on its Light Adjustable Lens system for cataract surgery patients, and its filings offer detailed insight into how this business is developing.

RxSight uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered topics such as quarterly and interim financial results, including revenue composition between Light Adjustable Lenses and Light Delivery Devices, and leadership changes involving the Chief Financial Officer and Board of Directors. These filings often reference accompanying press releases that provide additional context on procedure volumes, installed base metrics for Light Delivery Devices, and guidance ranges.

Other SEC reports, such as quarterly and annual filings (Forms 10-Q and 10-K), typically include more extensive information on RxSight’s single reportable segment, which encompasses research and development, manufacturing, and sale of Light Adjustable Lenses and related capital equipment. They also describe operating expenses, cash and investment balances, and non-GAAP measures like adjusted net earnings (loss) that exclude stock-based compensation.

On this page, Stock Titan surfaces RxSight’s SEC filings in real time as they become available from EDGAR and pairs them with AI-powered summaries. These summaries are designed to highlight key points—such as changes in operating performance, governance updates, or material agreements—so readers can quickly understand the significance of each document without reading every line.

Investors, analysts, and other interested readers can use this RXST filings page to review Forms 8-K, 10-Q, 10-K, and related exhibits, as well as to monitor ongoing disclosures about RxSight’s Light Adjustable Lens business, financial condition, and corporate governance.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.84%
Tags
current report

FAQ

How many Rxsight (RXST) SEC filings are available on StockTitan?

StockTitan tracks 31 SEC filings for Rxsight (RXST), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Rxsight (RXST)?

The most recent SEC filing for Rxsight (RXST) was filed on July 8, 2025.